Physician

Charlotte Smith Hand, MD

According to 2025 Medicare claims, Charlotte Hand, MD (NPI: 1093219339) practices dermatology in the Augusta-Richmond County, GA-SC market, with the plurality of this provider's patient population coming from Columbia, GA. This provider's primary affiliated billing organization is DERMATOLOGY SPECIALISTS OF AUGUSTA, INC (NPI: 1558339275; TIN: 311836454) and primary practice location at 30909-1854.

Hand's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 937 traditional Medicare patients, billed 3,492 HCPCS/CPT codes, and received $236,978 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,659 prescription claims across 523 beneficiaries totaling $1,263,978 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 144 records totaling $2,410. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $582 to $1,263,978. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$118K$237K2022 Medicare payment: $30,971 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $209,877 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $236,978 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022151466$30,971
20237613,309$209,877
20249373,492$236,978

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$632K$1.3M2018 Drug cost: $582 (USD; Tot_Drug_Cst)2019 Drug cost: $128,404 (USD; Tot_Drug_Cst)2020 Drug cost: $614,411 (USD; Tot_Drug_Cst)2021 Drug cost: $357,976 (USD; Tot_Drug_Cst)2022 Drug cost: $254,239 (USD; Tot_Drug_Cst)2023 Drug cost: $614,477 (USD; Tot_Drug_Cst)2024 Drug cost: $1,263,978 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/R15$582
2019118264$128,404
2020139520$614,411
202193277$357,976
2022109309$254,239
20234291,244$614,477
20245231,659$1,263,978

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more275358$78
17110Destruction of skin growth, 1-14 growths203237$73
11102Biopsy of related skin growth, first growth291357$59
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more453550$57
17000Destruction of precancer skin growth, 1 growth271333$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab22616$230,995
OtezlaApremilast431,288$224,059
Dupixent PenDupilumab381,050$153,783
Clobetasol PropionateClobetasol Propionate3429,413$15,054
TacrolimusTacrolimus351,065$3,955

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.144$2,410ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Charlotte Smith Hand, MD?

Tedicare shows public-source Medicare data for Charlotte Smith Hand, MD (NPI 1093219339), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charlotte Smith Hand, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Charlotte Smith Hand, MD?

Charlotte Smith Hand, MD is linked to DERMATOLOGY SPECIALISTS OF AUGUSTA, INC (billing NPI 1558339275) in the available physician profile data.

Does Charlotte Smith Hand, MD have Open Payments data?

Charlotte Smith Hand, MD has 144 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.